The Food and Drug Administration (FDA) this week approved 3 COVID-19 vaccines for the upcoming flu season. However, key restrictions that differ from years past include: fewer vaccine options for the youngest pediatric population; and generally no eligibility for those ages 5-64 who are healthy and not high-risk. In addition, FDA revoked emergency use authorizations for the vaccines, which had included a lower-dose option for children ages 6 months to 4 years. Announcements were posted …
Read More
